Hercules Capital, Inc. (HTGC) is now among the bigger bargains in its industry.
Within the last year the price ranged from $11.94 – 15.29 and there is a wide opportunity to get in. Its next earnings report will be released on Feb 20, 2020.

Karuna Therapeutics, Inc.(KRTX)

move, based on 6 analysts offering 12 month price targets for Karuna Therapeutics in the last 3 months. The average price target is $119.33 with a high forecast of $134.00 and a low forecast of $105.00. The average price target represents a 19.67% increase from the last price of $99.72.

Analysts like Vamil Divan from Mizuho Securities believe that we could see stock price minimum $120.00.

Another prominent analyst, Myles Minter of William Blair rates KRTX as a Buy. The rating was made just 2 months ago.

Karuna Therapeutics, Inc.(KRTX) Recent News Reports

On average 0.0 articles are written each week about KRTX but this week 0 articles were written and they were 63% Bullish and 37% Bearish.

Karuna Therapeutics, Inc. Target Levels

Some other stocks to consider in this sector are: